DW News published this video item, entitled “Vaccinations between health and geo-politics | COVID-19 Special” – below is their description.
The COVID-19 immunisation drive is expected to be largest in world history, and that too, within a relatively short time. Gaps may arise, and divisions emerge, as the world is getting “bifurcated” according to their vaccine providers, in an “East vs West” kind of equation. The inactivated vaccine platform used by Sinovac, Sinopharm, Sputnik V and Bharat Biotech means they are more “stable”, i.e. they don’t need super-cooling, and therefore can offer hope for the underdeveloped parts of the world. Chinese, Russian and Indian-made vaccines have proven attractive to lower and middle income countries, especially the ones who lack the capacity to sustain an ultra-freezing chain needed by mRNA vaccines.”
DW News YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.
About This Source - DW News
DW News is a global English-language news and information channel from German public international broadcaster Deutsche Welle, established in summer 2015.
India, officially the Republic of India, is a country in South Asia. It is the second-most populous country, the seventh-largest country by land area, and the most populous democracy in the world. New Delhi is the capital.
It has an exceptionally diverse population, with Hindus, Muslims, Christians, Sikhs, Buddhists, Jains and other religions speaking over 21 recognised languages.
China National Pharmaceutical Group Corp. known as Sinopharm is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine. Shanghai Shyndec Pharmaceutical and Beijing Tiantan Biological Products.
Gam-COVID-Vac, trade-named Sputnik V, is a COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology, and registered on 11 August 2020 by the Russian Ministry of Health. It has been approved for distribution in Russia.
The phase III trial for Gam-COVID-Vac was registered on 28 August 2020, and is a randomised, double-blind, placebo-controlled, multi-centre clinical trial involving 40,000 volunteers. The phase III trial is scheduled to run until May 2021.
On 5 December 2020, Russia began mass vaccinations in Moscow, with 70 clinics inoculating those most at risk from the virus. Health workers and teachers were said to have priority in the first mass immunisation programme. People who had received injections in the last 30 days or had respiratory diseases in the previous two weeks were excluded, as well as those with certain chronic illnesses, and pregnant and breastfeeding women.
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.